抑制剂简介
抑制剂是一类能够降低或阻止生物体内的酶活性、受体的活性或是细胞内特定反应过程的小分子化合物。它们在有机化学、化学化工和生物医药领域中有着广泛的应用,尤其是在药物研发方面。
分类与作用机制
应用领域
总结
抑制剂的研究和发展对于理解生命过程至关重要,并在药物开发、基础科学研究等多个领域发挥着重要作用。随着技术的进步,新的抑制剂不断被发现和开发出来,为医学治疗提供了更多的可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
N-((4-(4-苯基噻唑-2-基)四氢-2H-吡喃-4-基)甲基)-3-(5-(三氟甲基)-1,2,4-恶二唑-3-基)苯甲酰胺 | TMP-269 | 1314890-29-3 | C25H21F3N4O3S |
|
N-((2-羟基-6-甲基-4-丙基-3-吡啶基)甲基)-1-异丙基-6-(2-(4-甲基-1-哌嗪基)-4-吡啶基)-1H-吲唑-4-甲酰胺 | N-[(1,2-dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1- methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4- carboxamide | 1346704-33-3 | C31H39N7O2 |
|
N,N-二甲基-2-{3-[(1S)-1-(2-吡啶基)乙基]-1H-茚-2-基}乙胺 (2Z)-2-丁烯二酸盐(1:1) | N,N-Dimethyl-2-{3-[(1S)-1-(pyridin-2-yl)ethyl]-1H-inden-2-yl}ethan-1-aminium | 121367-05-3 | C20H25N2+ |
|
N,N-二乙基-4-(5-羟基螺[2H-1-苯并吡喃-2,4'-哌啶]-4-基)苯甲酰胺盐酸盐 | ADL5859 HCl | 850173-95-4 | C24H28N2O3*ClH |
|
N,N,N-三甲基-2-[(二甲氨基)甲酰氧基]苯铵甲磺酸盐 | 3-(4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol | 371935-74-9 | C19H16N4O3 |
|
N,N'-[1,4-亚苯基双(亚甲基)]双(吡啶-2-胺) | WZ811 | 55778-02-4 | C18H18N4 |
|
N'-(3,4-二羟基亚苄基)-3-羟基-2-萘甲酰肼 | dynasore | 304448-55-3 | C18H14N2O4 |
|
MYOSINII抑制剂((-)-BLEBBISTATIN) | blebbistatin | 856925-71-8 | C18H16N2O2 |
|
MPS1抑制剂(AZ3146) | az3146 | 1124329-14-1 | C24H32N6O3 |
|
MLN0905; 2-[[5-[3-(二甲基氨基)丙基]-2-甲基-3-吡啶基]氨基]-5,7-二氢-9-(三氟甲基)- 6H-嘧啶并[5,4-d][1]苯并氮杂卓-6-硫酮 | 2-[[5-[3-(dimethylamino)propyl]-2-methyl-3-pyridinyl]amino]-5,7-dihydro-9-(trifluoromethyl)-6H-pyrimido[5,4-d][1]benzazepine-6-thione | 1228960-69-7 | C24H25F3N6S |
|
MK-8033; 3-(1-甲基-1H-吡唑-4-基)-5-氧代-N-(2-吡啶甲基)-5H-苯并[4,5]环己烯并[1,2-b]吡啶-7-甲磺酰胺 | MK-8033 | 1001917-37-8 | C25H21N5O3S |
|
MGCD-265 类似物 | N-((3-fluoro-4-((2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)carbamothioyl)-2-phenylacetamide | 875337-44-3 | C26H20FN5O2S2 |
|
MC 1568; 3-[4-[3-(3-氟苯基)-3-氧代-1-丙烯基]-1-甲基-1H-吡咯-2-基]-N-羟基-2-丙烯酰胺 | MC1568 | 852475-26-4 | C17H15FN2O3 |
|
LY2835219甲磺酸盐 | abemaciclib methanesulfonate | 1231930-82-7 | CH4O3S*C27H32F2N8 |
|
LY-2584702 对甲苯磺酸盐 | 4-{4-[4-(4-fluoro-3-trifluoromethyl-phenyl)-1-methyl-1H-imidazol-2-yl]-piperidin-1-yl}-1H-pyrazolo[3,4-d]pyrimidine p-toluenesulfonate | 1082949-68-5 | C7H8O3S*C21H19F4N7 |
|
LY 2940680; 4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺 | LY2940680 | 1258861-20-9 | C26H24F4N6O |
|
LY 2886721; N-[3-[(4aS,7aS)-2-氨基-4a,5-二氢-4H-呋喃并[3,4-d][1,3]噻嗪-7a(7H)-基]-4-氟苯基]-5-氟-2-吡啶甲酰胺 | N-[3-[(4aS,7aS)-2-amino-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl]-4-fluorophenyl]-5-fluoro-2-pyridinecarboxamide | 1262036-50-9 | C18H16F2N4O2S |
|
LY 2157299; 4-[5,6-二氢-2-(6-甲基-2-吡啶基)-4H-吡咯并[1,2-b]吡唑-3-基]-6-喹啉甲酰胺 | galunisertib | 700874-72-2 | C22H19N5O |
|
LDN-57444抑制剂 | UCH-L1 Inhibitor | 668467-91-2 | C17H11Cl3N2O3 |
|
LCL161,凋亡蛋白抑制因子抑制剂 | (2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide | 1005342-46-0 | C26H33FN4O3S |
|
Ki 16425; 3-[[[4-[4-[[[1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]苯基]甲基]硫基]丙酸 | (+/-)-Ki16425 | 355025-24-0 | C23H23ClN2O5S |
|
KY02111抑制剂 | N-(6-chlorobenzo[d]thiazol-2-yl)-3-(3,4-dimethoxyphenyl)propanamide | 1118807-13-8 | C18H17ClN2O3S |
|
KX 01; 5-[4-[2-(4-吗啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺 | KX2-391 | 897016-82-9 | C26H29N3O3 |
|
KRN 633; N-[2-氯-4-[(6,7-二甲氧基-4-喹唑啉基)氧基]苯基]-N'-丙基脲 | KRN633 | 286370-15-8 | C20H21ClN4O4 |
|
KPT185抑制剂 | KPT-185 | 1333151-73-7 | C16H16F3N3O3 |
|
KN-93(水溶性) | N-[2-[N-(4-Chlorocinnamyl)-N-methylaminomethyl]phenyl]-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide phosphate salt | 1188890-41-6 | C26H29ClN2O4S*H3O4P |
|
KI 8751; N-(2,4-二氟苯基)-N'-[4-[(6,7-二甲氧基-4-喹啉基)氧基]-2-氟苯基]脲 | Ki 8751 | 228559-41-9 | C24H18F3N3O4 |
|
K-RAS(G12C)抑制剂6 | N-{1-[(2,4-Dichlorophenoxy)acetyl]piperidin-4-Yl}-4-Sulfanylbutanamide | 2060530-16-5 | C17H22Cl2N2O3S |
|
JZL184抑制剂 | 4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate | 1101854-58-3 | C27H24N2O9 |
|
Idasanutlin(4-((2R,3S,4R,5S)-3-(3-氯-2-氟苯基)-4-(4-氯-2-氟苯基)-4-氰基-5-新戊基吡咯烷-2-甲酰胺)-3-甲氧基苯甲酸;) | idasanutlin | 1229705-06-9 | C31H29Cl2F2N3O4 |
|
IWP2;N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2d]嘧啶-2-基)硫基]乙酰胺 | N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide | 686770-61-6 | C22H18N4O2S3 |
|
IU1抑制剂 | 1-[1-(4-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(pyrrolidin-1-yl)ethan-1-one | 314245-33-5 | C18H21FN2O |
|
IKK-16,选择性IKK抑制剂 | IKK Inhibitor VII | 873225-46-8 | C28H29N5OS |
|
HSP90抑制剂(VER-49009) | VER 49009 | 940289-57-6 | C19H18ClN3O4 |
|
HIV-1衣壳抑制剂GS-6207 | N-((S)-1-(3-(4-chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide | 2189684-44-2 | C39H32ClF10N7O5S2 |
|
HDAC6抑制剂(HPOB) | HPOB | 1429651-50-2 | C17H18N2O4 |
|
GZD824甲磺酸盐 | GZD824 Dimesylate | 1421783-64-3 | C31H35F3N6O7S2 |
|
GSK2334470游离态 | GKS2334470 | 1227911-45-6 | C25H34N8O |
|
GSK-3抑制剂(LY2090314) | 7-(2,5-dihydro-4-imidazo[1,2-a]pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo[3,2,1-jk][1,4]benzodiazepine | 603288-22-8 | C28H25FN6O3 |
|
GSK-2110183C无结构图 | afuresertib | 1047644-62-1 | C18H17Cl2FN4OS |
|
GSK 525762A; (4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-a][1,4]苯并二氮杂卓-4-乙酰胺 | I-BET762 | 1260907-17-2 | C22H22ClN5O2 |
|
GSK 1059615; (5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 | GSK1059615 | 958852-01-2 | C18H11N3O2S |
|
GNE-0877抑制剂 | 2-methyl-2-(3-methyl-4-((4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)propanenitrile | 1374828-69-9 | C14H16F3N7 |
|
GDC-0349; N-Ethyl-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-d]嘧啶-2-基]苯基]脲 | (S)-1-ethyl-3-(4-(4-(3-methylmorpholino)-7-(oxetan-3-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)phenyl)urea | 1207360-89-1 | C24H32N6O3 |
|
FR180204,一种ATP-竞争性的选择性的ERK抑制剂 | FR180204 | 865362-74-9 | C18H13N7 |
|
FK-506一水合物 | Tacrolimus monohydrate | 109581-93-3 | C44H71NO13 |
|
FGFR抑制剂(NVP-BGJ398) | BGJ398 | 872511-34-7 | C26H31Cl2N7O3 |
|
EZH2甲基转移酶抑制剂(GSK126) | GSK-126 | 1346574-57-9 | C31H38N6O2 |
|
EPZ005687抑制剂 | EPZ005687 | 1396772-26-1 | C32H37N5O3 |
|
EMD-1214063; 3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-哌啶基)甲氧基]-2-嘧啶基]苯基]甲基]-6-氧代-3-哒嗪基]苯腈 | tepotinib | 1100598-32-0 | C29H28N6O2 |
|